🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial tests safety, side effects and best dose of B-cell activ...
Status
Recruiting
Location
Mayo Clinic in Florida
Start Date
2024-03-18
Trial ID
NCT06191887
This phase I trial finds the best dose of PVEK when given together with flu...
Status
Active Not Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-18
Trial ID
NCT06034470
This phase Ib trial tests the safety, side effects and best dose of cluster...
Status
Suspended
Location
University of California, San Francisco
Start Date
2026-02-28
Trial ID
NCT07340853
This phase I trial studies the safety and feasibility of cytomegalovirus (C...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2023-09-29
Trial ID
NCT05801913
The purpose of this research is to provide comparative data about the Avitu...
Status
Recruiting
Location
Mayo Clinic
Start Date
2025-11-06
Trial ID
NCT07434505
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as clofarabine, work in differe...
Status
Terminated
Location
Knight Cancer Institute at Oregon Health and Science University
Start Date
2008-05
Trial ID
NCT00691652
This phase I trial tests the safety, side effects, and best dose of imetels...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2025-02-04
Trial ID
NCT06247787
This phase III trial studies combination chemotherapy with or without lesta...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2008-01-15
Trial ID
NCT00557193
Treatments Being Tested
This phase II trial studies how well administering ruxolitinib before, duri...
Status
Active Not Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2020-12-18
Trial ID
NCT04384692
Treatments Being Tested
The surface protein IL-1RAP, expressed by leukemic blast cells, represents ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05
Trial ID
NCT07455500
Treatments Being Tested